S M Snapinn

发表

Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.

S. Snapinn, C. Sweet, J H MacKay, 1996, Archives of internal medicine.

Estimation of error rates in discriminant analysis with selection of variables.

J D Knoke, S. Snapinn, J. Knoke, 1989, Biometrics.

A discriminant analysis extension to mixed models.

R W Helms, L. Tomasko, S. Snapinn, 1999, Statistics in medicine.

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

B. Brenner, H. Parving, G. Remuzzi, 2001, The New England journal of medicine.

Evaluating the efficacy of a combination therapy.

S. Snapinn, S M Snapinn, Steven M. Snapinn, 1987, Statistics in medicine.

Survival analysis with uncertain endpoints.

S. Snapinn, S M Snapinn, 1998, Biometrics.

Tests of significance using regression models for ordered categorical data.

S. Snapinn, S M Snapinn, R D Small, 1986, Biometrics.

[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].

B. Brenner, H. Parving, G. Remuzzi, 2001, Ugeskrift for laeger.

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.

E. Antman, E. Braunwald, D. Morrow, 2002, European heart journal.

Monitoring clinical trials with a conditional probability stopping rule.

S. Snapinn, S M Snapinn, 1992, Statistics in medicine.